Cl. Friedrich et al., Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria, ANTIM AG CH, 44(8), 2000, pp. 2086-2092
Antimicrobial cationic peptides are ubiquitous in nature and are thought to
be a component of the first line of defense against infectious agents. It
is widely believed that the killing mechanism of these peptides on bacteria
involves an interaction with the cytoplasmic membrane. Cationic peptides f
rom different structural classes were used in experiments with Staphylococc
us aureus and other medically important gram-positive bacteria to gain insi
ght into the mechanism of action. The membrane potential-sensitive fluoroph
ore dipropylthiacarbo-cyanine was used to assess the interactions of select
ed antimicrobial peptides with the cytoplasmic membrane of S. aureus. Study
of the kinetics of killing and membrane depolarization showed that, at ear
ly time points, membrane depolarization was incomplete, even when 90% or mo
re of the bacteria had been killed, CP26, a 26-amino-acid alpha-helical pep
tide with a high MIC against S, aureus, still had the ability to permeabili
ze the membrane. Cytoplasmic-membrane permeabilization was a nidespread abi
lity and an action that may be necessary for reaching an intracellular targ
et but in itself did not appear to be the killing mechanism. Transmission e
lectron microscopy of S. aureus and Staphylococcus epidermidis treated with
CP29 (a 26-amino-acid alpha-helical peptide), CP11CN (a 13-amino-acid, pro
line- and tryptophan-rich peptide), and Bac2A-NH2 (a linearized version of
the 12-amino acid loop peptide bactenecin) showed variability in effects on
bacterial structure. Mesosome-like structures were seen to develop in S. a
ureus, whereas cell wall effects and mesosomes were seen with S, epidermidi
s. Nuclear condensation and abherrent septation were occasionally seen in S
. epidermidis. Our experiments indicated that these peptides vary in their
mechanisms of action and that the mechanism of action likely does not solel
y involve cytoplasmic-membrane permeabilization.